UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.705

Sortiert nach

Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer

European journal of pharmacology, 2018-09, Vol.835, p.61-74

2018

Link zum Volltext

Verfügbarkeit prüfen

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response

Experimental hematology, 2007-10, Vol.35 (10), p.1527-1537

2007

Link zum Volltext

Verfügbarkeit prüfen

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile

Molecules (Basel, Switzerland), 2021-12, Vol.27 (1), p.104

2021

Link zum Volltext

Verfügbarkeit prüfen

Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth

Biomaterials, 2018-06, Vol.167, p.69-79

2018

Link zum Volltext

Verfügbarkeit prüfen

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

Current neuropharmacology, 2019-01, Vol.17 (10), p.926-946

2019

Link zum Volltext

Verfügbarkeit prüfen

Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism

Pharmacology, biochemistry and behavior, 2014-11, Vol.126, p.43-49

2014

Link zum Volltext

Verfügbarkeit prüfen

Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study

Progress in neuro-psychopharmacology & biological psychiatry, 2021-06, Vol.108, p.110185-110185, Article 110185

2021

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylation Inhibition in Pulmonary Hypertension Therapeutic Potential of Valproic Acid and Suberoylanilide Hydroxamic Acid

Circulation (New York, N.Y.), 2012-07, Vol.126 (4), p.455-467

2012

Link zum Volltext

Verfügbarkeit prüfen

Hidden pharmacological activities of valproic acid: A new insight

Biomedicine & pharmacotherapy, 2021-10, Vol.142, p.112021, Article 112021

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice

Psychopharmacology, 2024-02, Vol.241 (2), p.327-340

2024

Link zum Volltext

Verfügbarkeit prüfen

The pharmacogenomics of valproic acid

Journal of human genetics, 2017-12, Vol.62 (12), p.1009-1014

2017

Link zum Volltext

Verfügbarkeit prüfen

The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy

Scientific reports, 2016-11, Vol.6 (1), p.36250-36250, Article 36250

2016

Link zum Volltext

Verfügbarkeit prüfen

Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction

European journal of pharmacology, 2024-05, Vol.970, p.176475-176475, Article 176475

2024

Link zum Volltext

Verfügbarkeit prüfen

Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats

Brain research bulletin, 2019-04, Vol.147, p.36-46

2019

Link zum Volltext

Verfügbarkeit prüfen

Photo-uncaging of BODIPY oxime ester for histone deacetylases induced apoptosis in tumor cells

Chemical communications (Cambridge, England), 2019-12, Vol.55 (94), p.14162-14165

2019

Link zum Volltext

Verfügbarkeit prüfen

HPLC-UV and GC-MS Methods for Determination of Chlorambucil and Valproic Acid in Plasma for Further Exploring a New Combined Therapy of Chronic Lymphocytic Leukemia

Molecules (Basel, Switzerland), 2021-05, Vol.26 (10), p.2903

2021

Link zum Volltext

Verfügbarkeit prüfen

Valproic acid reverses sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in hepatocellular carcinoma

Fundamental & clinical pharmacology, 2021-08, Vol.35 (4), p.690-699

2021

Link zum Volltext

Verfügbarkeit prüfen

Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression

Phytomedicine (Stuttgart), 2024-04, Vol.126, p.155459-155459, Article 155459

2024

Link zum Volltext

Verfügbarkeit prüfen

Prenatal exposure to valproic acid reduces synaptic δ-catenin levels and disrupts ultrasonic vocalization in neonates

Neuropharmacology, 2024-08, Vol.253, p.109963-109963, Article 109963

2024

Link zum Volltext

Verfügbarkeit prüfen

Fucoxanthin mitigates valproic acid-induced autistic behavior through modulation of the AKT/GSK-3β signaling pathway

European journal of pharmacology, 2024-03, Vol.967, p.176335-176335, Article 176335

2024

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats

Journal of ethnopharmacology, 2022-07, Vol.293, p.115199-115199, Article 115199

2022

Link zum Volltext

Verfügbarkeit prüfen

Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy

Scientific reports, 2019-09, Vol.9 (1), p.13983-10, Article 13983

2019

Link zum Volltext

Verfügbarkeit prüfen

A valproic acid-modified platinum diimine complex as potential photosensitizer for photodynamic therapy

Journal of inorganic biochemistry, 2021-09, Vol.222, p.111508-111508, Article 111508

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France

Scientific reports, 2020-10, Vol.10 (1), p.17362, Article 17362

2020

Link zum Volltext

Verfügbarkeit prüfen

Metabolic and endocrine effects of valproic acid chronic treatment

Epilepsy research, 2013-11, Vol.107 (1), p.1-8

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.705

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.593)
Mit Volltextzugriff
(3.230)

Publikationsform

Artikel
(3.704)
Buchkapitel
(1)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.401)
Life Sciences & Biomedicine
(3.251)
Humans
(2.084)
Valproic Acid - Pharmacology
(1.858)
Animals
(1.766)
Male
(1.751)
Biological And Medical Sciences
(1.626)
Valproic Acid
(1.563)
Medical Sciences
(1.561)
Pharmacology & Pharmacy
(1.476)
Pharmacology. Drug Treatments
(1.392)
Female
(1.302)
Neurosciences & Neurology
(1.296)
Neuropharmacology
(939)
Valproic Acid - Therapeutic Use
(879)
Neurosciences
(876)
Rats
(869)
Adult
(670)
Clinical Neurology
(657)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(612)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Therapeutic Drug Monitoring
(150)
Epilepsy Research
(136)
Plos One
(108)
European Journal Of Pharmacology
(104)
Neurology
(103)
Neuropharmacology
(87)
Brain Research
(76)
Biochemical Pharmacology
(69)
Pharmacology, Biochemistry And Behavior
(66)
Journal Of Affective Disorders
(60)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer

Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile

Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth

Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism

Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study

Histone Deacetylation Inhibition in Pulmonary Hypertension Therapeutic Potential of Valproic Acid and Suberoylanilide Hydroxamic Acid

Hidden pharmacological activities of valproic acid: A new insight

Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice

The pharmacogenomics of valproic acid

The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy

Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction

Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats

Photo-uncaging of BODIPY oxime ester for histone deacetylases induced apoptosis in tumor cells

HPLC-UV and GC-MS Methods for Determination of Chlorambucil and Valproic Acid in Plasma for Further Exploring a New Combined Therapy of Chronic Lymphocytic Leukemia

Valproic acid reverses sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in hepatocellular carcinoma

Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression

Prenatal exposure to valproic acid reduces synaptic δ-catenin levels and disrupts ultrasonic vocalization in neonates

Fucoxanthin mitigates valproic acid-induced autistic behavior through modulation of the AKT/GSK-3β signaling pathway

Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats

Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy

A valproic acid-modified platinum diimine complex as potential photosensitizer for photodynamic therapy

Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France

Metabolic and endocrine effects of valproic acid chronic treatment

Aktive Filter

Suchergebnisse filtern